## DOC: Healthpeak Properties, Inc. - XLRE: Real Estate

### Executive Summary

No thesis match: MRS_20 -7.1% below STRENGTH zone (4.0-10.0%); PEG 4.08 fails VALUE criteria (<1.0); RSI 27 oversold (REVERSION excluded per A/B test). Stock is in no-man's land without clear edge. Caution: momentum weakening (-3.1% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($15.29)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 2
- **Sentiment:** Bullish (Bullish: 0, Bearish: 0)

**1. AI, luxury and aging: how Maplewood is rethinking senior living with co-CEOs**
- Source: Stock Titan | 20251218T140222 | Neutral | Relevance: 65%
- Maplewood Senior Living has appointed long-time partners Shane Herlet and Tom Gaston as Co-CEOs, effective December 18, 2025, to lead its new chapter. The company is embracing advanced technology, including AI-driven recruitment and predictive analytics, to address industry challenges in workforce management, operational efficiency, and rising costs. Additionally, Maplewood plans to continue expanding its luxury Inspīr brand, supported by its financial partner Omega Healthcare Investors (OHI), with recent openings like Inspīr Embassy Row and the upcoming five-year anniversary of Inspīr Carnegie Hill.

**2. Medical Properties Trust (MPW): Evaluating Valuation After Dividend Hike and California Hospital Lease Progress**
- Source: Simply Wall Street | 20251218T041138 | Somewhat-Bullish | Relevance: 61%
- Medical Properties Trust (MPW) recently increased its quarterly dividend by over 12% and signed a new lease for six California hospitals, aiming to reassure investors about cash flow and tenant risk. Despite recent share price fluctuations, MPW shows a positive year-to-date return, suggesting cautious optimism. While analysts expect earnings to recover significantly by 2028, substantial asset impairments and refinancing costs remain key risks to its valuation.

### Analyst Activity

**Target Signal:** BEARISH (Raises: 1, Lowers: 2)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-16 | Jefferies | $17 | $21 | -19% |
| 2025-12-15 | Evercore ISI Gr | $21 | $22 | -5% |
| 2025-11-25 | Wells Fargo | $19 | $18 | +6% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-16 | Jefferies | down | Hold |
| 2025-12-15 | Evercore ISI Gr | main | Outperform |
| 2025-11-25 | Wells Fargo | main | Equal-Weight |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 57.9% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 5 |

**Top Holders:**
- Vanguard Group Inc: 15.7% (-1.9%)
- Blackrock Inc.: 10.5% (-1.7%)
- JPMORGAN CHASE & CO: 8.1% (+182.0%)
- State Street Corpora: 7.1% (+1.8%)
- Principal Financial : 3.9% (-3.2%)

### Key Risks

1. Momentum deterioration: MRS_20 falling (-3.1% 5d) with bearish MACD, trend may be turning.
2. Valuation risk: PEG 4.1x with declining EPS estimates leaves no margin for error.
3. Long-term trend broken: trading 11.4% below SMA200.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 4.08 signals overvaluation risk, limited margin of safety. Analyst sentiment negative (2 target cuts vs 1 raises). Institutional flow bullish (5 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $11.1B |
| Beta | 1.09 |
| 52W Range | $15.98 - $21.28 |
| Short Interest | 4.1% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 4.08 |
| Forward P/E | 64.0 |
| Current P/E | N/A |
| YoY Growth | N/A |
| EPS Direction | FALLING |

### Technicals

MRS_20 deteriorating from -4.0% to -7.1% (-3.1% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 11.1pp (needs >4.0% for momentum thesis). AM_20 at -6.8% indicates price below own 20MA trend. Underperforming sector by 5.4pp, stock-specific weakness. Below SMA200 (0.89x), long-term trend not supportive. RSI oversold at 27, potential bounce setup. OFD pattern: -FTH (Decline).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -7.08% (CS: 5) | Weak |
| RSI_14 | 27.1 | Oversold |
| MACD Histogram | -0.08 | Bearish |
| vs SMA20 | 0.932x | Below |
| vs SMA50 | 0.906x | Below |
| vs SMA200 | 0.886x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $15.99
- **Stop Loss:** $15.29 (4.4% risk)
- **Target:** $16.69 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 857
- **Position Value:** $13,703.43
- **Portfolio %:** 13.70%
- **Risk Dollars:** $600.00
- **Risk Per Trade:** 0.60%
- **Modifiers:** L1 120% | L2 50% | Combined 0.60x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with improving risk appetite as VIX falls to 6th percentile and tech rally resumes on AI infrastructure demand. Fed pause expectations from cooling CPI data support equities, though elevated put/call ratio suggests cautious positioning. Focus on quality names in AI-exposed sectors.*

### Earnings

**Next:** 2026-02-05 (Est: $0.06)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.06 | $-0.18 | -403.2% |
| 2025Q2 | $0.06 | $0.06 | +12.2% |
| 2025Q1 | $0.04 | $0.06 | +40.7% |
| 2024Q4 | $0.05 | $0.05 | -4.7% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*